| Filed | Description | |
|---|---|---|
| 4/30/25 | 1.01 Material Agreement | → |
| 3/4/25 | 1.01 Material Agreement | → |
| 10/24/24 | 1.01 Material Agreement | → |
| 3/14/24 | 1.01 Material Agreement | → |
| 4/13/23 | 1.01 Material Agreement | → |
| 1/6/23 | 1.02 Agreement Terminated | → |
| ↓ 13 more | ||
Regulus Therapeutics Inc. is a clinical stage biopharmaceutical company focused on the development of first-in-class drugs that target microRNAs to treat a broad range of diseases.